Efficacy and Safety of the 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Fluvastatin in Hyperlipidemic Patients Treated with Probucol

Susumu Sasaki,Masao Nakagawa,T. Nakata,Naoto Endo,K. Miyao,K. Kitamura,M. Fukuyama,T. Kitani,C. Yamada

Efficacy and Safety of the 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Fluvastatin in Hyperlipidemic Patients Treated with Probucol

1997

Susumu Sasaki
Masao Nakagawa
T. Nakata
Naoto Endo
K. Miyao
K. Kitamura
M. Fukuyama
T. Kitani
C. Yamada

The objective of this open trial was to investigate the efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor fluvastatin in hypercholesterolemic patients alre

Keywords:

Probucol
Fluvastatin
HMG-CoA reductase
Reductase
Hyperlipidemia
Apolipoprotein B
Internal medicine
Enzyme inhibitor
Endocrinology
Medicine
Coenzyme A
Chemotherapy
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations